Clinical trial for children with concussion

This study is investigating repetitive Transcranial Magnetic Stimulation (rTMS) as potential treatment for children with persistent post-concussion symptom. 

Participants will be randomised to receive either 10 rTMS treatment or sham treatment (placebo/dummy) over 2 weeks, with the option to receive a further two weeks of 10 rTMS treatment sessions. 

Study assessments include advanced brain imaging and activity measurements such as magnetic resonance imaging (MRI) and electroencephalography (EEG), as well as questionnaires to assess well-being and changes in symptoms. 

The study will take place in the KidStim Lab at the Centre for Children’s Health Research. 

Who is eligible to participate? 

  • Children, adolescents and young adults aged 11-25 years with a diagnosis of post-concussion syndrome.
  • Have two or more symptoms persisting for at least two months. 
  • Children who do not have epilepsy or other seizure disorders. 

To learn more about the study or to see if you/your child is eligible, please contact Rebecca Greenslade on  07 3069 7456 or or click on the register button below.